Spine firm Vexim shoots for €17.5m in IPO
This article was originally published in Clinica
Executive Summary
French kyphoplasty specialist Vexim is aiming to raise up to €17.45m ($22.77m) in an initial public offering, further boosting hopes of a revival in the medtech IPO market.